Incyte to Report Third Quarter 2013 Financial Results on October 31

Incyte to Report Third Quarter 2013 Financial Results on October 31

WILMINGTON, Del.--(BUSINESS WIRE)-- Incyte Corporation (NAS: INCY) announced today that it has scheduled its third quarter conference call for 8:30 a.m. ET on Thursday, October 31, 2013. The schedules for the press release and conference call are as follows:

   -- Q3 2013 Press Release:       October 31, 2013 at 7:00 a.m. ET
-- Q3 2013 Conference Call:October 31, 2013 at 8:30 a.m. ET
-- Domestic Dial In Number:877-407-8037
-- International Dial In Number:201-689-8037
-- Conference ID #421882

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference ID number 421882.

The conference call will also be webcast live and can be accessed at under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, please visit the Company's web site at

Incyte Corporation
Pamela M. Murphy
Vice President, Investor Relations & Corporate Communications

KEYWORDS:   United States  North America  Delaware


The article Incyte to Report Third Quarter 2013 Financial Results on October 31 originally appeared on

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Can't get enough business news?

Sign up for Finance Report by AOL and get everything from retailer news to the latest IPOs delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.